Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.62 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.62 |
| ▸ | STAT3 | P40763 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | FLT3 | P36888 | 2/20 | 0.58 |
| ▸ | CDK2 | P24941 | 2/20 | 0.58 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.58 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.58 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.57 |
| ▸ | WNT3A | P56704 | 3/20 | 0.57 |
| ▸ | IDO1 | P14902 | 1/20 | 0.55 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | EPHB3 | P54753 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2175299 | 0.98 | KDM4E (0.60) | KDM4EYTHDC1STAT3HIF1AFLT3 | |
| Hydrochloric Acid SCHEMBL30404733 | 0.98 | KDM4E (0.60) | KDM4EYTHDC1STAT3HIF1AFLT3 | |
| Hydrochloric Acid SCHEMBL29962256 | 0.98 | KDM4E (0.60) | KDM4EYTHDC1STAT3HIF1AFLT3 | |
| Hydrochloric Acid SCHEMBL5071439 | 0.98 | KDM4E (0.60) | KDM4EYTHDC1STAT3HIF1AFLT3 | |
| Oxalic Acid SCHEMBL6033591 | 0.95 | FLT3 (0.58) | KDM4EYTHDC1STAT3HIF1AFLT3 | |
| Formic Acid SCHEMBL5987899 | 0.93 | KDM4E (0.55) | KDM4EYTHDC1STAT3HIF1AFLT3 | |
| Trifluoroacetic Acid SCHEMBL15546473 | 0.90 | FLT3 (0.54) | KDM4EYTHDC1STAT3HIF1AFLT3 | |
| SCHEMBL1962245 | 0.87 | CYP1A2 (0.54) | KDM4EYTHDC1STAT3HIF1AFLT3 | |
| SCHEMBL28388762 | 0.86 | KDM4E (0.49) | KDM4EYTHDC1STAT3HIF1AFLT3 | |
| SCHEMBL31148407 | 0.84 | KDM4E (0.66) | KDM4EYTHDC1STAT3HIF1AFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1355 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3597184-B1 | INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | KOREA RES INST CHEMICAL TECH (KR) | 2026-03-04 | — | — | EP | claimed |
| CN-121586714-A | Connected bicyclic compounds for control and combating invertebrate pests | FMC公司 | 2026-02-27 | — | — | CN | claimed |
| EP-4301736-B1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2025-10-08 | — | — | EP | claimed |
| US-20250243181-A2 | NOVEL INDAZOLE DERIVATIVE AND USE THEREOF | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2025-07-31 | — | — | US | claimed |
| CN-119907790-A | Pyrazole amide insecticidal agents | FMC公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119907626-A | Compositions having pesticidal utility and methods related thereto | 科迪华农业科技有限责任公司 | 2025-04-29 | — | — | CN | claimed |
| US-20250092014-A1 | COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE | METREA BIOSCIENCES INC (US) | 2025-03-20 | — | — | US | claimed |
| CN-119136797-A | CB1Ligand conjugated compounds and uses thereof | 阿达尔克斯制药有限公司 | 2024-12-13 | — | — | CN | claimed |
| EP-4469461-A1 | TETRAHYDROPYRANOPYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER AND VIRAL INFECTIONS | Genase Therapeutics B.V. (NL) | 2024-12-04 | — | — | EP | claimed |
| EP-4186894-B1 | FGFR INHIBITOR COMPOUND AND USE THEREOF | HENAN MEDINNO PHARMACEUTICAL TECH CO LTD (CN) | 2024-12-04 | — | — | EP | claimed |
| EP-0975623-B1 | INDAZOLE AMIDE COMPOUNDS AS SEROTONINERGIC AGENTS | ACRAF (IT) | 2002-06-19 | — | — | EP | claimed |
| WO-2002036114-A1 | COMPOSITION COMPRISING SEROTONIN RECEPTOR ANTAGONISTS, 5 HT-2 AND 5 HT-3 | RESPIRATORIUS AB (SE) | 2002-05-10 | — | — | WO | claimed |
| WO-2002036113-A1 | COMPOSITION COMPRISING: SEROTONIN RECEPTOR ANTAGONISTS (5HT-2, 5HT-3) AND AGONIST (5HT-4) | RESPIRATORIUS AB (SE) | 2002-05-10 | — | — | WO | claimed |
| WO-2001095902-A9 | A COMPOSITION COMPRISING A COMBINATION OF RECEPTOR AGONISTS AND ANTAGONISTS | — | 2002-04-25 | — | — | WO | claimed |
| WO-2001095902-A1 | A COMPOSITION COMPRISING A COMBINATION OF RECEPTOR AGONISTS AND ANTAGONISTS | RESPIRATORIUS AB (SE) | 2001-12-20 | — | — | WO | claimed |
| US-6197769-B1 | SEROTONINE RECEPTORS ANTAGONIST; GASTROINTESTINAL DISORDERS, ANTIARRHYTHMIA AGENTS; INCONTINENCE | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2001-03-06 | — | — | US | claimed |
| CN-1252798-A | Indazole amide compounds as 5-serotoninergic agents | ANGELINI RICERCHE SPA (IT) | 2000-05-10 | — | — | CN | claimed |
| EP-0975623-A2 | INDAZOLE AMIDE COMPOUNDS AS SEROTONINERGIC AGENTS | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) | 2000-02-02 | — | — | EP | claimed |
| WO-1998046589-B1 | INDAZOLE AMIDE COMPOUNDS AS SEROTONINERGIC AGENTS | — | 1999-03-04 | — | — | WO | claimed |
| WO-1998046589-A2 | INDAZOLE AMIDE COMPOUNDS AS SEROTONINERGIC AGENTS | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 1998-10-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250243181-A2 | NOVEL INDAZOLE DERIVATIVE AND USE THEREOF | TRIB2, YAP1, IDO2 | KDM4E 2690/4885YTHDC1 2450/4885STAT3 2087/4885 |
| US-20250092014-A1 | COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE | LPL, LIPA, PNLIP | KDM4E 4122/4885YTHDC1 4861/4885STAT3 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.